Merve Demir
Kocaeli, 41000, Turkey (Türkiye)
NCT Number: NCT05588986
The purpose of this study is to evaluate the effect of antenatal corticosteroid administration on umbilical artery Doppler velocimetry measurements in pregnancies complicated by IUGR.
Looking for future studies?
Notify Me18 year–49 year
Female
Observational
Kocaeli, 41000, Turkey (Türkiye)
This study was conducted with pregnant women who were likely to have preterm birth and were treated with antenatal corticosteroids. Betamethasone was used as an antenatal corticosteroid. UA Doppler measurements (PI, S/D ratio, RI) before antenatal corticosteroid administration and 24 and 48 hours after the last dose of corticosteroid administration were evaluated in pregnant groups complicated with IUGR and uncomplicated with IUGR and compared with each other.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
pregnant women who were likely to have preterm delivery and were treated with antenatal corticosteroids.
Exclusion criteria
Pregnant women who had complicated pregnancy with fetal anomaly, who had multiple pregnancies, who left their pregnancy follow-up unfinished, and those under 18 years of age were excluded from the study.
Umbilical artery Doppler evaluation by ultrasonography just before the first dose of antenatal corticosteroid, 24 hours and 48 hours after the last dose.
Time frame: 2018-2019
Peak systolic velocity/end diastolic velocity
Time frame: 2018-2019
Pulsatility Index (PI) = (Peak systolic velocity - end diastolic velocity)/(time averaged maximum velocity)
Time frame: 2018-2019
Resistive Index (RI) = (Peak systolic velocity - end diastolic velocity)/(peak systolic velocity)
Merve Demir
Other
The Effect of Antenatal Corticosteroid Administration on Umbilical Artery Doppler Velocimetry in Pregnant Women Complicated With IUGR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02238301
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Paris, France
View Trial DetailsNCT06988436
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Cairo, Egypt
View Trial DetailsNCT05253781
Anemia, Anemia, Hemolytic
Ajegunle, Lagos, Nigeria
View Trial DetailsNCT02523222
Birth Weight, Body Weight
Houston, Texas, United States
View Trial Details